智通财经APP获悉，威高股份(01066)早盘涨近7%，截至发稿，涨6.71%，报4.61港元，成交额1525.44万港元。
消息面上，1月21日，威高骨科发布2024年业绩预告。报告期内，公司预计实现归母净利润2亿元-2.4亿元，同比增长78.07%-113.68%。骨科耗材带量采购全面执行进入平稳期，公司积极执行带量采购政策，主动调整经营策略，重新规划产品线、优化成本控制、强化与医疗机构的合作关系，以及探索多元化市场渠道，最大限度提高市场份额和客户覆盖率，实现财报增长。
中泰国际此前指出，山东威高为拥有广阔销售网络的著名医疗耗材生产商。预计2024-26E药品包装业务收入将实现较快增长，骨科产品收入2024年起将重拾增长；介入业务收入将维持稳健增长，医疗器械板块即将走出集采阴霾。该行指出，2025年起业绩增速将加快，首予“买入”评级，目标价5.6港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.